TY - STD TI - Dhillon AS, Tulchinsky E. FRA-1 as a driver of tumour heterogeneity: a nexus between oncogenes and embryonic signalling pathways in cancer. Oncogene. 2015; 34(34):4421-8. ID - ref1 ER - TY - JOUR AU - Tam, W. L. AU - Lu, H. AU - Buikhuisen, J. AU - Soh, B. S. AU - Lim, E. AU - Reinhardt, F. AU - Wu, Z. J. AU - Krall, J. A. AU - Bierie, B. AU - Guo, W. PY - 2013 DA - 2013// TI - Protein kinase C alpha is a central signaling node and therapeutic target for breast cancer stem cells JO - Cancer Cell VL - 24 UR - https://doi.org/10.1016/j.ccr.2013.08.005 DO - 10.1016/j.ccr.2013.08.005 ID - Tam2013 ER - TY - JOUR AU - Milde-Langosch, K. PY - 2005 DA - 2005// TI - The Fos family of transcription factors and their role in tumourigenesis JO - Eur J Cancer VL - 41 UR - https://doi.org/10.1016/j.ejca.2005.08.008 DO - 10.1016/j.ejca.2005.08.008 ID - Milde-Langosch2005 ER - TY - JOUR AU - Eferl, R. AU - Wagner, E. F. PY - 2003 DA - 2003// TI - AP-1: a double-edged sword in tumorigenesis JO - Nat Rev Cancer VL - 3 UR - https://doi.org/10.1038/nrc1209 DO - 10.1038/nrc1209 ID - Eferl2003 ER - TY - JOUR AU - Bergers, G. AU - Graninger, P. AU - Braselmann, S. AU - Wrighton, C. AU - Busslinger, M. PY - 1995 DA - 1995// TI - Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron JO - Mol Cell Biol VL - 15 UR - https://doi.org/10.1128/MCB.15.7.3748 DO - 10.1128/MCB.15.7.3748 ID - Bergers1995 ER - TY - STD TI - Maurus K, Hufnagel A, Geiger F, Graf S, Berking C, Heinemann A, Paschen A, Kneitz S, Stigloher C, Geissinger E, et al. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation. Oncogene. 2017. ID - ref6 ER - TY - JOUR AU - Verde, P. AU - Casalino, L. AU - Talotta, F. AU - Yaniv, M. AU - Weitzman, J. B. PY - 2007 DA - 2007// TI - Deciphering AP-1 function in tumorigenesis: fra-ternizing on target promoters JO - Cell Cycle VL - 6 UR - https://doi.org/10.4161/cc.6.21.4850 DO - 10.4161/cc.6.21.4850 ID - Verde2007 ER - TY - JOUR AU - Iskit, S. AU - Schlicker, A. AU - Wessels, L. AU - Peeper, D. S. PY - 2015 DA - 2015// TI - Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.6454 DO - 10.18632/oncotarget.6454 ID - Iskit2015 ER - TY - JOUR AU - Gallenne, T. AU - Ross, K. N. AU - Visser, N. L. AU - Salony AU - Desmet, C. J. AU - Wittner, B. S. AU - Wessels, L. F. A. AU - Ramaswamy, S. AU - Peeper, D. S. PY - 2017 DA - 2017// TI - Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.16244 DO - 10.18632/oncotarget.16244 ID - Gallenne2017 ER - TY - JOUR AU - Desmet, C. J. AU - Gallenne, T. AU - Prieur, A. AU - Reyal, F. AU - Visser, N. L. AU - Wittner, B. S. AU - Smit, M. A. AU - Geiger, T. R. AU - Laoukili, J. AU - Iskit, S. PY - 2013 DA - 2013// TI - Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis JO - Proc Natl Acad Sci USA VL - 110 UR - https://doi.org/10.1073/pnas.1222085110 DO - 10.1073/pnas.1222085110 ID - Desmet2013 ER - TY - JOUR AU - Belguise, K. AU - Milord, S. AU - Galtier, F. AU - Moquet-Torcy, G. AU - Piechaczyk, M. AU - Chalbos, D. PY - 2012 DA - 2012// TI - The PKCtheta pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells JO - Oncogene VL - 31 UR - https://doi.org/10.1038/onc.2011.659 DO - 10.1038/onc.2011.659 ID - Belguise2012 ER - TY - JOUR AU - Belguise, K. AU - Kersual, N. AU - Galtier, F. AU - Chalbos, D. PY - 2005 DA - 2005// TI - FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells JO - Oncogene VL - 24 UR - https://doi.org/10.1038/sj.onc.1208312 DO - 10.1038/sj.onc.1208312 ID - Belguise2005 ER - TY - JOUR AU - Yang, S. AU - Li, Y. AU - Gao, J. AU - Zhang, T. AU - Li, S. AU - Luo, A. AU - Chen, H. AU - Ding, F. AU - Wang, X. AU - Liu, Z. PY - 2013 DA - 2013// TI - MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1 JO - Oncogene VL - 32 UR - https://doi.org/10.1038/onc.2012.432 DO - 10.1038/onc.2012.432 ID - Yang2013 ER - TY - JOUR AU - Song, Y. AU - Song, S. AU - Zhang, D. AU - Zhang, Y. AU - Chen, L. AU - Qian, L. AU - Shi, M. AU - Zhao, H. AU - Jiang, Z. AU - Guo, N. PY - 2006 DA - 2006// TI - An association of a simultaneous nuclear and cytoplasmic localization of Fra-1 with breast malignancy JO - BMC Cancer. VL - 6 UR - https://doi.org/10.1186/1471-2407-6-298 DO - 10.1186/1471-2407-6-298 ID - Song2006 ER - TY - JOUR AU - Chiappetta, G. AU - Ferraro, A. AU - Botti, G. AU - Monaco, M. AU - Pasquinelli, R. AU - Vuttariello, E. AU - Arnaldi, L. AU - Bonito, M. AU - D'Aiuto, G. AU - Pierantoni, G. M. PY - 2007 DA - 2007// TI - FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders JO - BMC Cancer. VL - 7 UR - https://doi.org/10.1186/1471-2407-7-17 DO - 10.1186/1471-2407-7-17 ID - Chiappetta2007 ER - TY - JOUR AU - Logullo, A. F. AU - Stiepcich, M. M. AU - Osorio, C. A. AU - Nonogaki, S. AU - Pasini, F. S. AU - Rocha, R. M. AU - Soares, F. A. AU - Brentani, M. M. PY - 2011 DA - 2011// TI - Role of Fos-related antigen 1 in the progression and prognosis of ductal breast carcinoma JO - Histopathology VL - 58 UR - https://doi.org/10.1111/j.1365-2559.2011.03785.x DO - 10.1111/j.1365-2559.2011.03785.x ID - Logullo2011 ER - TY - JOUR AU - Bakiri, L. AU - Macho-Maschler, S. AU - Custic, I. AU - Niemiec, J. AU - Guio-Carrion, A. AU - Hasenfuss, S. C. AU - Eger, A. AU - Muller, M. AU - Beug, H. AU - Wagner, E. F. PY - 2015 DA - 2015// TI - Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFbeta expression JO - Cell Death Differ VL - 22 UR - https://doi.org/10.1038/cdd.2014.157 DO - 10.1038/cdd.2014.157 ID - Bakiri2015 ER - TY - JOUR AU - Zhao, C. AU - Qiao, Y. AU - Jonsson, P. AU - Wang, J. AU - Xu, L. AU - Rouhi, P. AU - Sinha, I. AU - Cao, Y. AU - Williams, C. AU - Dahlman-Wright, K. PY - 2014 DA - 2014// TI - Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-13-3396 DO - 10.1158/0008-5472.CAN-13-3396 ID - Zhao2014 ER - TY - STD TI - Oliveira-Ferrer L, Kurschner M, Labitzky V, Wicklein D, Muller V, Luers G, Schumacher U, Milde-Langosch K, Schroder C. Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties. J Cancer Res Clin Oncol. 2015;141(10):1715-26. ID - ref19 ER - TY - JOUR AU - Diesch, J. AU - Sanij, E. AU - Gilan, O. AU - Love, C. AU - Tran, H. AU - Fleming, N. I. AU - Ellul, J. AU - Amalia, M. AU - Haviv, I. AU - Pearson, R. B. PY - 2014 DA - 2014// TI - Widespread FRA1-dependent control of mesenchymal transdifferentiation programs in colorectal cancer cells JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0088950 DO - 10.1371/journal.pone.0088950 ID - Diesch2014 ER - TY - JOUR AU - Moquet-Torcy, G. AU - Tolza, C. AU - Piechaczyk, M. AU - Jariel-Encontre, I. PY - 2014 DA - 2014// TI - Transcriptional complexity and roles of Fra-1/AP-1 at the uPA/Plau locus in aggressive breast cancer JO - Nucleic Acids Res VL - 42 UR - https://doi.org/10.1093/nar/gku814 DO - 10.1093/nar/gku814 ID - Moquet-Torcy2014 ER - TY - JOUR AU - Henckels, E. AU - Prywes, R. PY - 2013 DA - 2013// TI - Fra-1 regulation of Matrix Metallopeptidase-1 (MMP-1) in metastatic variants of MDA-MB-231 breast cancer cells JO - F1000Res VL - 2 ID - Henckels2013 ER - TY - JOUR AU - Sayan, A. E. AU - Stanford, R. AU - Vickery, R. AU - Grigorenko, E. AU - Diesch, J. AU - Kulbicki, K. AU - Edwards, R. AU - Pal, R. AU - Greaves, P. AU - Jariel-Encontre, I. PY - 2012 DA - 2012// TI - Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL JO - Oncogene VL - 31 UR - https://doi.org/10.1038/onc.2011.336 DO - 10.1038/onc.2011.336 ID - Sayan2012 ER - TY - STD TI - Stinson S, Lackner MR, Adai AT, Yu N, Kim HJ, O'Brien C, Spoerke J, Jhunjhunwala S, Boyd Z, Januario T,  et al. TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer. Sci Signal. 2011;4(177):ra41. ID - ref24 ER - TY - JOUR AU - Leconet, W. AU - Chentouf, M. AU - Manoir, S. AU - Chevalier, C. AU - Sirvent, A. AU - Ait-Arsa, I. AU - Busson, M. AU - Jarlier, M. AU - Radosevic-Robin, N. AU - Theillet, C. PY - 2017 DA - 2017// TI - Therapeutic activity of anti-AXL antibody against triple-negative breast cancer patient-derived xenografts and metastasis JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-1316 DO - 10.1158/1078-0432.CCR-16-1316 ID - Leconet2017 ER - TY - JOUR AU - Chen, R. H. AU - Abate, C. AU - Blenis, J. PY - 1993 DA - 1993// TI - Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase JO - Proc Natl Acad Sci USA VL - 90 UR - https://doi.org/10.1073/pnas.90.23.10952 DO - 10.1073/pnas.90.23.10952 ID - Chen1993 ER - TY - JOUR AU - Chen, R. H. AU - Juo, P. C. AU - Curran, T. AU - Blenis, J. PY - 1996 DA - 1996// TI - Phosphorylation of c-Fos at the C-terminus enhances its transforming activity JO - Oncogene VL - 12 ID - Chen1996 ER - TY - JOUR AU - Basbous, J. AU - Chalbos, D. AU - Hipskind, R. AU - Jariel-Encontre, I. AU - Piechaczyk, M. PY - 2007 DA - 2007// TI - Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer JO - Mol Cell Biol VL - 27 UR - https://doi.org/10.1128/MCB.01776-06 DO - 10.1128/MCB.01776-06 ID - Basbous2007 ER - TY - JOUR AU - Vial, E. AU - Marshall, C. J. PY - 2003 DA - 2003// TI - Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells JO - J Cell Sci VL - 116 UR - https://doi.org/10.1242/jcs.00812 DO - 10.1242/jcs.00812 ID - Vial2003 ER - TY - JOUR AU - Casalino, L. AU - Cesare, D. AU - Verde, P. PY - 2003 DA - 2003// TI - Accumulation of Fra-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization JO - Mol Cell Biol VL - 23 UR - https://doi.org/10.1128/MCB.23.12.4401-4415.2003 DO - 10.1128/MCB.23.12.4401-4415.2003 ID - Casalino2003 ER - TY - JOUR AU - Shin, S. AU - Dimitri, C. A. AU - Yoon, S. O. AU - Dowdle, W. AU - Blenis, J. PY - 2010 DA - 2010// TI - ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events JO - Mol Cell VL - 38 UR - https://doi.org/10.1016/j.molcel.2010.02.020 DO - 10.1016/j.molcel.2010.02.020 ID - Shin2010 ER - TY - JOUR AU - Zoumpourlis, V. AU - Papassava, P. AU - Linardopoulos, S. AU - Gillespie, D. AU - Balmain, A. AU - Pintzas, A. PY - 2000 DA - 2000// TI - High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model JO - Oncogene VL - 19 UR - https://doi.org/10.1038/sj.onc.1203732 DO - 10.1038/sj.onc.1203732 ID - Zoumpourlis2000 ER - TY - JOUR AU - Young, M. R. AU - Nair, R. AU - Bucheimer, N. AU - Tulsian, P. AU - Brown, N. AU - Chapp, C. AU - Hsu, T. C. AU - Colburn, N. H. PY - 2002 DA - 2002// TI - Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently JO - Mol Cell Biol VL - 22 UR - https://doi.org/10.1128/MCB.22.2.587-598.2002 DO - 10.1128/MCB.22.2.587-598.2002 ID - Young2002 ER - TY - JOUR AU - Adiseshaiah, P. AU - Vaz, M. AU - Machireddy, N. AU - Kalvakolanu, D. V. AU - Reddy, S. P. PY - 2008 DA - 2008// TI - A Fra-1-dependent, matrix metalloproteinase driven EGFR activation promotes human lung epithelial cell motility and invasion JO - J Cell Physiol VL - 216 UR - https://doi.org/10.1002/jcp.21410 DO - 10.1002/jcp.21410 ID - Adiseshaiah2008 ER - TY - JOUR AU - Ramos-Nino, M. E. AU - Blumen, S. R. AU - Sabo-Attwood, T. AU - Pass, H. AU - Carbone, M. AU - Testa, J. R. AU - Altomare, D. A. AU - Mossman, B. T. PY - 2008 DA - 2008// TI - HGF mediates cell proliferation of human mesothelioma cells through a PI3K/MEK5/Fra-1 pathway JO - Am J Respir Cell Mol Biol VL - 38 UR - https://doi.org/10.1165/rcmb.2007-0206OC DO - 10.1165/rcmb.2007-0206OC ID - Ramos-Nino2008 ER - TY - JOUR AU - Belguise, K. AU - Cherradi, S. AU - Sarr, A. AU - Boissiere, F. AU - Boulle, N. AU - Simony-Lafontaine, J. AU - Choesmel-Cadamuro, V. AU - Wang, X. AU - Chalbos, D. PY - 2017 DA - 2017// TI - PKCtheta-induced phosphorylations control the ability of Fra-1 to stimulate gene expression and cancer cell migration JO - Cancer Lett. VL - 385 UR - https://doi.org/10.1016/j.canlet.2016.10.038 DO - 10.1016/j.canlet.2016.10.038 ID - Belguise2017 ER - TY - JOUR AU - Laplante, Y. AU - Rancourt, C. AU - Poirier, D. PY - 2009 DA - 2009// TI - Relative involvement of three 17β-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors JO - Mol Cell Endocrinol VL - 301 UR - https://doi.org/10.1016/j.mce.2008.08.026 DO - 10.1016/j.mce.2008.08.026 ID - Laplante2009 ER - TY - JOUR AU - Neve, R. M. AU - Chin, K. AU - Fridlyand, J. AU - Yeh, J. AU - Baehner, F. L. AU - Fevr, T. AU - Clark, L. AU - Bayani, N. AU - Coppe, J. -. P. AU - Tong, F. PY - 2006 DA - 2006// TI - A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes JO - Cancer Cell VL - 10 UR - https://doi.org/10.1016/j.ccr.2006.10.008 DO - 10.1016/j.ccr.2006.10.008 ID - Neve2006 ER - TY - JOUR AU - Northey, J. J. AU - Chmielecki, J. AU - Ngan, E. AU - Russo, C. AU - Annis, M. G. AU - Muller, W. J. AU - Siegel, P. M. PY - 2008 DA - 2008// TI - Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion JO - Mol Cell Biol VL - 28 UR - https://doi.org/10.1128/MCB.01734-07 DO - 10.1128/MCB.01734-07 ID - Northey2008 ER - TY - JOUR AU - Puiffe, M. L. AU - Page, C. AU - Filali-Mouhim, A. AU - Zietarska, M. AU - Ouellet, V. AU - Tonin, P. N. AU - Chevrette, M. AU - Provencher, D. M. AU - Mes-Masson, A. M. PY - 2007 DA - 2007// TI - Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer JO - Neoplasia VL - 9 UR - https://doi.org/10.1593/neo.07472 DO - 10.1593/neo.07472 ID - Puiffe2007 ER - TY - JOUR AU - Tusher, V. G. AU - Tibshirani, R. AU - Chu, G. PY - 2001 DA - 2001// TI - Significance analysis of microarrays applied to the ionizing radiation response JO - Proc Natl Acad Sci USA VL - 98 UR - https://doi.org/10.1073/pnas.091062498 DO - 10.1073/pnas.091062498 ID - Tusher2001 ER - TY - JOUR AU - Gyorffy, B. AU - Lanczky, A. AU - Eklund, A. C. AU - Denkert, C. AU - Budczies, J. AU - Li, Q. AU - Szallasi, Z. PY - 2010 DA - 2010// TI - An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients JO - Breast Cancer Res Treat VL - 123 UR - https://doi.org/10.1007/s10549-009-0674-9 DO - 10.1007/s10549-009-0674-9 ID - Gyorffy2010 ER - TY - JOUR AU - Masuda, H. AU - Zhang, D. AU - Bartholomeusz, C. AU - Doihara, H. AU - Hortobagyi, G. N. AU - Ueno, N. T. PY - 2012 DA - 2012// TI - Role of epidermal growth factor receptor in breast cancer JO - Breast Cancer Res Treat VL - 136 UR - https://doi.org/10.1007/s10549-012-2289-9 DO - 10.1007/s10549-012-2289-9 ID - Masuda2012 ER - TY - JOUR AU - Murphy, L. O. AU - MacKeigan, J. P. AU - Blenis, J. PY - 2004 DA - 2004// TI - A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration JO - Mol Cell Biol VL - 24 UR - https://doi.org/10.1128/MCB.24.1.144-153.2004 DO - 10.1128/MCB.24.1.144-153.2004 ID - Murphy2004 ER - TY - JOUR AU - Zheng, M. W. AU - Zhang, C. H. AU - Chen, K. AU - Huang, M. AU - Li, Y. P. AU - Lin, W. T. AU - Zhang, R. J. AU - Zhong, L. AU - Xiang, R. AU - Li, L. L. PY - 2016 DA - 2016// TI - Preclinical evaluation of a novel orally available SRC/Raf/VEGFR2 inhibitor, SKLB646, in the treatment of triple-negative breast cancer JO - Mol Cancer Ther VL - 15 UR - https://doi.org/10.1158/1535-7163.MCT-15-0501 DO - 10.1158/1535-7163.MCT-15-0501 ID - Zheng2016 ER - TY - JOUR AU - Xue, W. AU - Mizukami, I. AU - Todd, R. F. AU - Petty, H. R. PY - 1997 DA - 1997// TI - Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components JO - Cancer Res VL - 57 ID - Xue1997 ER - TY - JOUR AU - Kjoller, L. AU - Hall, A. PY - 2001 DA - 2001// TI - Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin JO - J Cell Biol VL - 152 UR - https://doi.org/10.1083/jcb.152.6.1145 DO - 10.1083/jcb.152.6.1145 ID - Kjoller2001 ER - TY - JOUR AU - Leupold, J. H. AU - Asangani, I. AU - Maurer, G. D. AU - Lengyel, E. AU - Post, S. AU - Allgayer, H. PY - 2007 DA - 2007// TI - Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer JO - Mol Cancer Res VL - 5 UR - https://doi.org/10.1158/1541-7786.MCR-06-0211 DO - 10.1158/1541-7786.MCR-06-0211 ID - Leupold2007 ER - TY - JOUR AU - DeRose, Y. S. AU - Wang, G. AU - Lin, Y. C. AU - Bernard, P. S. AU - Buys, S. S. AU - Ebbert, M. T. AU - Factor, R. AU - Matsen, C. AU - Milash, B. A. AU - Nelson, E. PY - 2011 DA - 2011// TI - Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes JO - Nat Med VL - 17 UR - https://doi.org/10.1038/nm.2454 DO - 10.1038/nm.2454 ID - DeRose2011 ER - TY - JOUR AU - Zhang, X. AU - Claerhout, S. AU - Prat, A. AU - Dobrolecki, L. E. AU - Petrovic, I. AU - Lai, Q. AU - Landis, M. D. AU - Wiechmann, L. AU - Schiff, R. AU - Giuliano, M. PY - 2013 DA - 2013// TI - A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-12-4081 DO - 10.1158/0008-5472.CAN-12-4081 ID - Zhang2013 ER - TY - JOUR AU - Schvartz, I. AU - Seger, D. AU - Shaltiel, S. PY - 1999 DA - 1999// TI - Vitronectin JO - Int J Biochem Cell Biol VL - 31 UR - https://doi.org/10.1016/S1357-2725(99)00005-9 DO - 10.1016/S1357-2725(99)00005-9 ID - Schvartz1999 ER - TY - JOUR AU - Pola, C. AU - Formenti, S. C. AU - Schneider, R. J. PY - 2013 DA - 2013// TI - Vitronectin-alphavbeta3 integrin engagement directs hypoxia-resistant mTOR activity and sustained protein synthesis linked to invasion by breast cancer cells JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-13-0218 DO - 10.1158/0008-5472.CAN-13-0218 ID - Pola2013 ER - TY - STD TI - Pirazzoli V, Ferraris GMS, Sidenius N. Direct evidence of the importance of vitronectin and its interaction with the urokinase receptor in tumor growth. Blood. 2013;121(12):2316-23. ID - ref53 ER - TY - JOUR AU - Kadowaki, M. AU - Sangai, T. AU - Nagashima, T. AU - Sakakibara, M. AU - Yoshitomi, H. AU - Takano, S. AU - Sogawa, K. AU - Umemura, H. AU - Fushimi, K. AU - Nakatani, Y. PY - 2011 DA - 2011// TI - Identification of vitronectin as a novel serum marker for early breast cancer detection using a new proteomic approach JO - J Cancer Res Clin Oncol VL - 137 UR - https://doi.org/10.1007/s00432-010-0974-9 DO - 10.1007/s00432-010-0974-9 ID - Kadowaki2011 ER - TY - JOUR AU - Vial, E. AU - Sahai, E. AU - Marshall, C. J. PY - 2003 DA - 2003// TI - ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility JO - Cancer Cell VL - 4 UR - https://doi.org/10.1016/S1535-6108(03)00162-4 DO - 10.1016/S1535-6108(03)00162-4 ID - Vial2003 ER - TY - JOUR AU - Thun, A. AU - Preisinger, C. AU - Rath, O. AU - Schwarz, J. P. AU - Ward, C. AU - Monsefi, N. AU - Rodríguez, J. AU - Garcia-Munoz, A. AU - Birtwistle, M. AU - Bienvenut, W. PY - 2013 DA - 2013// TI - Extracellular signal-regulated kinase regulates rhoa activation and tumor cell plasticity by inhibiting guanine exchange factor H1 activity JO - Mol Cell Biol VL - 33 UR - https://doi.org/10.1128/MCB.00585-13 DO - 10.1128/MCB.00585-13 ID - Thun2013 ER - TY - JOUR AU - Smith, H. W. AU - Marra, P. AU - Marshall, C. J. PY - 2008 DA - 2008// TI - uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180 JO - J Cell Biol VL - 182 UR - https://doi.org/10.1083/jcb.200712050 DO - 10.1083/jcb.200712050 ID - Smith2008 ER - TY - JOUR AU - Noh, H. AU - Hong, S. AU - Huang, S. PY - 2013 DA - 2013// TI - Role of urokinase receptor in tumor progression and development JO - Theranostics VL - 3 UR - https://doi.org/10.7150/thno.4218 DO - 10.7150/thno.4218 ID - Noh2013 ER - TY - JOUR AU - Smith, H. W. AU - Marshall, C. J. PY - 2010 DA - 2010// TI - Regulation of cell signalling by uPAR JO - Nat Rev Mol Cell Biol VL - 11 UR - https://doi.org/10.1038/nrm2821 DO - 10.1038/nrm2821 ID - Smith2010 ER - TY - JOUR AU - Madsen, C. D. AU - Ferraris, G. M. AU - Andolfo, A. AU - Cunningham, O. AU - Sidenius, N. PY - 2007 DA - 2007// TI - uPAR-induced cell adhesion and migration: vitronectin provides the key JO - J Cell Biol VL - 177 UR - https://doi.org/10.1083/jcb.200612058 DO - 10.1083/jcb.200612058 ID - Madsen2007 ER - TY - JOUR AU - Wei, C. AU - Moller, C. C. AU - Altintas, M. M. AU - Li, J. AU - Schwarz, K. AU - Zacchigna, S. AU - Xie, L. AU - Henger, A. AU - Schmid, H. AU - Rastaldi, M. P. PY - 2008 DA - 2008// TI - Modification of kidney barrier function by the urokinase receptor JO - Nat Med VL - 14 UR - https://doi.org/10.1038/nm1696 DO - 10.1038/nm1696 ID - Wei2008 ER - TY - JOUR AU - Ferraris, G. M. S. AU - Schulte, C. AU - Buttiglione, V. AU - Lorenzi, V. AU - Piontini, A. AU - Galluzzi, M. AU - Podestà, A. AU - Madsen, C. D. AU - Sidenius, N. PY - 2014 DA - 2014// TI - The interaction between uPAR and vitronectin triggers ligand-independent adhesion signalling by integrins JO - EMBO J VL - 33 UR - https://doi.org/10.15252/embj.201387611 DO - 10.15252/embj.201387611 ID - Ferraris2014 ER - TY - JOUR AU - Huai, Q. AU - Zhou, A. AU - Lin, L. AU - Mazar, A. P. AU - Parry, G. C. AU - Callahan, J. AU - Shaw, D. E. AU - Furie, B. AU - Furie, B. C. AU - Huang, M. PY - 2008 DA - 2008// TI - Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes JO - Nat Struct Mol Biol VL - 15 UR - https://doi.org/10.1038/nsmb.1404 DO - 10.1038/nsmb.1404 ID - Huai2008 ER - TY - JOUR AU - Gardsvoll, H. AU - Ploug, M. PY - 2007 DA - 2007// TI - Mapping of the vitronectin-binding site on the urokinase receptor: involvement of a coherent receptor interface consisting of residues from both domain I and the flanking interdomain linker region JO - J Biol Chem VL - 282 UR - https://doi.org/10.1074/jbc.M610184200 DO - 10.1074/jbc.M610184200 ID - Gardsvoll2007 ER - TY - JOUR AU - Ellis, V. AU - Behrendt, N. AU - Dano, K. PY - 1991 DA - 1991// TI - Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor JO - J Biol Chem VL - 266 ID - Ellis1991 ER - TY - JOUR AU - Riisbro, R. AU - Christensen, I. J. AU - Piironen, T. AU - Greenall, M. AU - Larsen, B. AU - Stephens, R. W. AU - Han, C. AU - Hoyer-Hansen, G. AU - Smith, K. AU - Brunner, N. PY - 2002 DA - 2002// TI - Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer JO - Clin Cancer Res VL - 8 ID - Riisbro2002 ER - TY - JOUR AU - Montuori, N. AU - Pesapane, A. AU - Rossi, F. W. AU - Giudice, V. AU - Paulis, A. AU - Selleri, C. AU - Ragno, P. PY - 2016 DA - 2016// TI - Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer JO - Transl Med UniSa. VL - 15 ID - Montuori2016 ER - TY - JOUR AU - Liu, D. AU - Zhou, D. AU - Wang, B. AU - Knabe, W. E. AU - Meroueh, S. O. PY - 2015 DA - 2015// TI - A new class of orthosteric uPAR*uPA small-molecule antagonists are allosteric inhibitors of the uPAR*vitronectin interaction JO - ACS Chem Biol VL - 10 UR - https://doi.org/10.1021/cb500832q DO - 10.1021/cb500832q ID - Liu2015 ER - TY - JOUR AU - Ragone, C. AU - Minopoli, M. AU - Ingangi, V. AU - Botti, G. AU - Fratangelo, F. AU - Pessi, A. AU - Stoppelli, M. P. AU - Ascierto, P. A. AU - Ciliberto, G. AU - Motti, M. L. PY - 2017 DA - 2017// TI - Targeting the cross-talk between urokinase receptor and formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells JO - J Exp Clin Cancer Res VL - 36 UR - https://doi.org/10.1186/s13046-017-0650-x DO - 10.1186/s13046-017-0650-x ID - Ragone2017 ER -